These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27107789)

  • 1. Opportunities for the development of novel therapies based on host-microbial interactions.
    Santos PC; Teixeira MM; Souza DG
    Pharmacol Res; 2016 Oct; 112():68-83. PubMed ID: 27107789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK in Pathogens.
    Mesquita I; Moreira D; Sampaio-Marques B; Laforge M; Cordeiro-da-Silva A; Ludovico P; Estaquier J; Silvestre R
    Exp Suppl; 2016; 107():287-323. PubMed ID: 27812985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo.
    Ciarlo E; Heinonen T; Herderschee J; Fenwick C; Mombelli M; Le Roy D; Roger T
    Sci Rep; 2016 Nov; 6():37944. PubMed ID: 27897220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of interleukin-37 in infectious diseases.
    Allam G; Gaber AM; Othman SI; Abdel-Moneim A
    Int Rev Immunol; 2020; 39(1):3-10. PubMed ID: 31633447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions.
    Martinez-Martin N
    J Immunol Res; 2017; 2017():2197615. PubMed ID: 28321417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-directed drug targeting of factors hijacked by pathogens.
    Schwegmann A; Brombacher F
    Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The essential features of microorganisms and the rationale for antimicrobial therapy.
    Douglas CW
    Br Dent J; 1992 May; 172(9):339-43. PubMed ID: 1389584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides as the next generation of anti-infectives.
    Mercer DK; O'Neil DA
    Future Med Chem; 2013 Mar; 5(3):315-37. PubMed ID: 23464521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant probiotics with antimicrobial peptides: a dual strategy to improve immune response in immunocompromised patients.
    Mandal SM; Silva ON; Franco OL
    Drug Discov Today; 2014 Aug; 19(8):1045-50. PubMed ID: 24881782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of infections in cancer patients: a review.
    Sim SK
    Am J Hosp Pharm; 1975 Jan; 32(1):35-44. PubMed ID: 1092159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases.
    Zaiou M
    J Mol Med (Berl); 2007 Apr; 85(4):317-29. PubMed ID: 17216206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.
    Donnelly MC; Hayes PC; Simpson KJ
    World J Gastroenterol; 2016 Jul; 22(26):5958-70. PubMed ID: 27468190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defensin-based anti-infective strategies.
    Wilmes M; Sahl HG
    Int J Med Microbiol; 2014 Jan; 304(1):93-9. PubMed ID: 24119539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-directed therapies for bacterial and viral infections.
    Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
    Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between penicillins and lysozyme. Data which led to the synthesis of a new antibiotic salt: lysozyme ampicillinate. II.
    Pellegrini R; Vertova P
    Arzneimittelforschung; 1969 Feb; 19(2):149-53. PubMed ID: 4976648
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.
    Labro MT
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):319-40. PubMed ID: 22397566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to an infectious insult (e.g., bacterial or fungal infection).
    Teixeira MM; Cunha FQ; Ferreira SH
    Braz J Med Biol Res; 2001 May; 34(5):1 p preceding 555. PubMed ID: 11452953
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimicrobial resistance & 'Man's best friend': what they give to us we might be giving right back.
    Blondeau JM
    Future Microbiol; 2017 Jun; 12():549-553. PubMed ID: 28604102
    [No Abstract]   [Full Text] [Related]  

  • 19. Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives.
    Shah CP; Kharkar PS
    Future Med Chem; 2015; 7(11):1415-29. PubMed ID: 26230881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.
    Gjini E; Brito PH
    PLoS Comput Biol; 2016 Apr; 12(4):e1004857. PubMed ID: 27078624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.